MedPath

A randomized study about TURP complications due to Asiprin consumptio

Not Applicable
Conditions
Trasurethral resection of prostat.
Registration Number
IRCT20200122046220N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
132
Inclusion Criteria

Benign Prostatic Hyperplasia

Exclusion Criteria

End Stage Renal Disease (ESRD)
Cirrhosis
Received anticoagulant medications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post TURP hematuria due to Asiprin consumption. Timepoint: First 28 Days after TURP. Method of measurement: Hemoglobin decline.
Secondary Outcome Measures
NameTimeMethod
Cardiac complication after TURP. Timepoint: First 28 days after TURP. Method of measurement: Cardiac enzyme checks in suspected cases.
© Copyright 2025. All Rights Reserved by MedPath